Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1971 1
1972 1
1976 2
1977 1
1978 2
1979 2
1980 2
1982 1
1983 5
1984 3
1985 6
1986 4
1987 3
1988 9
1989 4
1990 6
1991 2
1992 5
1993 2
1994 1
1995 3
1996 5
1997 1
1998 7
1999 7
2000 3
2001 3
2002 5
2003 7
2004 7
2005 6
2006 9
2007 7
2008 6
2009 5
2010 8
2011 6
2012 6
2013 9
2014 10
2015 5
2016 11
2017 14
2018 9
2019 11
2020 16
2021 13
2022 11
2023 13
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

269 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for corey weight
Your search for Corey Weicht retrieved no results
Effectiveness of Intermittent Fasting and Time-Restricted Feeding Compared to Continuous Energy Restriction for Weight Loss.
Rynders CA, Thomas EA, Zaman A, Pan Z, Catenacci VA, Melanson EL. Rynders CA, et al. Nutrients. 2019 Oct 14;11(10):2442. doi: 10.3390/nu11102442. Nutrients. 2019. PMID: 31614992 Free PMC article. Review.
Current guidelines recommend continuous energy restriction (CER) along with a comprehensive lifestyle intervention as the cornerstone of obesity treatment, yet this approach produces modest weight loss on average. Recently, there has been increased interest in identifying …
Current guidelines recommend continuous energy restriction (CER) along with a comprehensive lifestyle intervention as the cornerstone of obe …
AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review.
Younossi ZM, Corey KE, Lim JK. Younossi ZM, et al. Gastroenterology. 2021 Feb;160(3):912-918. doi: 10.1053/j.gastro.2020.11.051. Epub 2020 Dec 9. Gastroenterology. 2021. PMID: 33307021 Review.
NAFLD cirrhosis is a leading indication for liver transplantation in the United States. Lifestyle modification to achieve weight loss remains a first-line intervention in patients with NAFLD. ...
NAFLD cirrhosis is a leading indication for liver transplantation in the United States. Lifestyle modification to achieve weight loss …
The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments.
Targher G, Corey KE, Byrne CD, Roden M. Targher G, et al. Nat Rev Gastroenterol Hepatol. 2021 Sep;18(9):599-612. doi: 10.1038/s41575-021-00448-y. Epub 2021 May 10. Nat Rev Gastroenterol Hepatol. 2021. PMID: 33972770 Review.
In addition, the improvement or resolution of NAFLD (on ultrasonography) is associated with a reduction of T2DM risk, adding weight to causality and suggesting that liver-focused treatments might reduce the risk of developing T2DM. ...
In addition, the improvement or resolution of NAFLD (on ultrasonography) is associated with a reduction of T2DM risk, adding weight t …
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE; S. aureus Endocarditis and Bacteremia Study Group. Fowler VG Jr, et al. N Engl J Med. 2006 Aug 17;355(7):653-65. doi: 10.1056/NEJMoa053783. N Engl J Med. 2006. PMID: 16914701 Free article. Clinical Trial.
METHODS: We randomly assigned 124 patients with S. aureus bacteremia with or without endocarditis to receive 6 mg of daptomycin intravenously per kilogram of body weight daily and 122 to receive initial low-dose gentamicin plus either an antistaphylococcal penicilli …
METHODS: We randomly assigned 124 patients with S. aureus bacteremia with or without endocarditis to receive 6 mg of daptomycin intravenousl …
Growth Hormone Administration Improves Nonalcoholic Fatty Liver Disease in Overweight/Obesity: A Randomized Trial.
Dichtel LE, Corey KE, Haines MS, Chicote ML, Lee H, Kimball A, Colling C, Simon TG, Long MT, Husseini J, Bredella MA, Miller KK. Dichtel LE, et al. J Clin Endocrinol Metab. 2023 Nov 17;108(12):e1542-e1550. doi: 10.1210/clinem/dgad375. J Clin Endocrinol Metab. 2023. PMID: 37379033 Clinical Trial.
There were no study discontinuations due to worsening of glycemic status, and there were no significant differences in change in glycemic measures or insulin resistance between the GH and placebo groups. CONCLUSION: GH administration reduces hepatic steatosis in adults wit …
There were no study discontinuations due to worsening of glycemic status, and there were no significant differences in change in glycemic …
The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: A multi-center study.
Stanford FC, Alfaris N, Gomez G, Ricks ET, Shukla AP, Corey KE, Pratt JS, Pomp A, Rubino F, Aronne LJ. Stanford FC, et al. Surg Obes Relat Dis. 2017 Mar;13(3):491-500. doi: 10.1016/j.soard.2016.10.018. Epub 2016 Oct 27. Surg Obes Relat Dis. 2017. PMID: 27986587 Free PMC article.
BACKGROUND: Patients who undergo bariatric surgery often have inadequate weight loss or weight regain. OBJECTIVES: We sought to discern the utility of weight loss pharmacotherapy as an adjunct to bariatric surgery in patients with inadequate weight los …
BACKGROUND: Patients who undergo bariatric surgery often have inadequate weight loss or weight regain. OBJECTIVES: We sought t …
Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis.
Corey KE, Rinella ME. Corey KE, et al. Dig Dis Sci. 2016 May;61(5):1387-97. doi: 10.1007/s10620-016-4083-8. Epub 2016 Mar 4. Dig Dis Sci. 2016. PMID: 26942734 Free PMC article. Review.
Treatment of NASH may decrease the risk of progressive disease. Treatment for NAFLD should center around weight loss and exercise. Pharmacotherapy with vitamin E and pioglitazone should be considered for those with NASH, especially those with fibrosis. Weight loss s …
Treatment of NASH may decrease the risk of progressive disease. Treatment for NAFLD should center around weight loss and exercise. Ph …
Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition.
Seaton KE, Huang Y, Karuna S, Heptinstall JR, Brackett C, Chiong K, Zhang L, Yates NL, Sampson M, Rudnicki E, Juraska M, deCamp AC, Edlefsen PT, Mullins JI, Williamson C, Rossenkhan R, Giorgi EE, Kenny A, Angier H, Randhawa A, Weiner JA, Rojas M, Sarzotti-Kelsoe M, Zhang L, Sawant S, Ackerman ME, McDermott AB, Mascola JR, Hural J, McElrath MJ, Andrew P, Hidalgo JA, Clark J, Laher F, Orrell C, Frank I, Gonzales P, Edupuganti S, Mgodi N, Corey L, Morris L, Montefiori D, Cohen MS, Gilbert PB, Tomaras GD. Seaton KE, et al. EBioMedicine. 2023 Jul;93:104590. doi: 10.1016/j.ebiom.2023.104590. Epub 2023 Jun 8. EBioMedicine. 2023. PMID: 37300931 Free PMC article.
We also compared fixed dosing vs. body weight-based dosing via simulations. FINDINGS: Estimated VRC01 concentrations in VRC01 recipients without HIV-1 were higher than those in VRC01 recipients who acquired HIV-1. Body weight was inversely associated w …
We also compared fixed dosing vs. body weight-based dosing via simulations. FINDINGS: Estimated VRC01 concentrations in VRC01 …
NAFLD in Cardiovascular Diseases: A Contributor or Comorbidity?
Chen B, Tang WHW, Rodriguez M, Corey KE, Sanyal AJ, Kamath PS, Bozkurt B, Virk HUH, Pressman GS, Lazarus JV, El-Serag HB, Krittanawong C. Chen B, et al. Semin Liver Dis. 2022 Nov;42(4):465-474. doi: 10.1055/s-0042-1757712. Epub 2022 Oct 14. Semin Liver Dis. 2022. PMID: 36241194 Review.
Although the specific underlying mechanisms are not clear, many hypotheses have been suggested, including that metabolic syndrome might act as an upstream metabolic defect, leading to end-organ manifestations in both the heart and liver. Management of NAFLD includes weight …
Although the specific underlying mechanisms are not clear, many hypotheses have been suggested, including that metabolic syndrome might act …
269 results